1.14.20.1: deacetoxycephalosporin-C synthase
This is an abbreviated version!
For detailed information about deacetoxycephalosporin-C synthase, go to the full flat file.
Word Map on EC 1.14.20.1
-
1.14.20.1
-
clavuligerus
-
chrysogenum
-
acremonium
-
isopenicillin
-
penicillium
-
beta-lactams
-
epimerase
-
cephamycins
-
cephalosporium
-
ring-expansion
-
7-aminodeacetoxycephalosporanic
-
pcbab
-
ironii
-
cephem
-
lactamdurans
-
synthesis
-
7-adca
-
2-oxoglutarate-dependent
-
cephalexin
-
carbenicillin
-
doacs
-
biotechnology
-
medicine
- 1.14.20.1
- clavuligerus
- chrysogenum
- acremonium
- isopenicillin
- penicillium
- beta-lactams
-
epimerase
-
cephamycins
- cephalosporium
-
ring-expansion
-
7-aminodeacetoxycephalosporanic
-
pcbab
-
ironii
-
cephem
- lactamdurans
- synthesis
-
7-adca
-
2-oxoglutarate-dependent
- cephalexin
- carbenicillin
-
doacs
- biotechnology
- medicine
Reaction
Synonyms
acDAOC/DACS, cefE, cefEF, Cephalosporin biosynthesis expandase/hydroxylase, DAOC synthase, DAOC/DAC synthase, DAOC/DACS, DAOCS, deacetoxy/deacetylcephalosporin C synthase, deacetoxycephalosporin C synthase, deacetoxycephalosporin-C synthase, deacetoxycephalosporin-C synthetase, deacetoxycephalosporin/deacetylcephalosporin C synthase, expandase, expendase, penicillin N expandase, scDAOCS
ECTree
Advanced search results
Engineering
Engineering on EC 1.14.20.1 - deacetoxycephalosporin-C synthase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DELTA310/M306I
site-directed mutagenesis, mutant selectively catalyzed the ring expansion with kinetics similar to the wild-type enzyme
DELTA310/N305L/M306I
site-directed mutagenesis, mutant selectively catalyzed the ring expansion, and shows a lower Km value than the wild-type enzyme and about 3fold improved kinetic parameters
M306I
N305L
R308A
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308C
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308D
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308E
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308F
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308G
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308H
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308I
-
site-directed mutagenesis, the mutant shows significant improvement in the ability to convert penicillin analogues compared to the wild-type enzyme. The mutant shows the highest reactivity for penicillin G, with 3fold increase in kcat/Km ratio and 7fold increase in relative activity
R308K
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308L
R308M
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308N
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308P
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308Q
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308S
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308T
-
site-directed mutagenesis, the mutant shows significant improvement in the ability to convert penicillin analogues compared to the wild-type enzyme
R308V
-
site-directed mutagenesis, the mutant shows significant improvement in the ability to convert penicillin analogues compared to the wild-type enzyme
R308W
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
R308Y
-
site-directed mutagenesis, the mutant shows altered substrate specificity compared to the wild-type enzyme
W82A
W82S
44% of wild-type ring expansion activity, 18% of wild-type hydroxylation activity
A106T
80% relative activity with 1 mM substrate and 170% relative activity with 10 mM penicillin G compared to wild-type activity detected with 1 mM penicillin G, 1.5fold reduction in Km, penicillin G as substrate
A11V/T91A/C281Y/I305L
220% relative activity with 1 mM and 200% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
A61E
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
C155Y
C155Y/Y184H/S261M/V275I/C281Y/I305M
site-directed mutagenesis, the mutant shows 87fold increased kcat/Km for penicillin G compared to the wild-type
C155Y/Y184H/V275I/C281Y
C281F
substrate ampicillin, 191%, penicillin G, 264%, phenethicillin, 300%, and carbenicillin, 518% of wild-type activity
C281Y
C281Y/I305M
C281Y/N304A
substrate ampicillin, 294%, penicillin G, 383%, phenethicillin, 714%, and carbenicillin, 911% of wild-type activity
C281Y/N304K
substrate ampicillin, 376%, penicillin G, 428%, phenethicillin, 948%, and carbenicillin, 1180% of wild-type activity
C281Y/N304L
substrate ampicillin, 330%, penicillin G, 211%, phenethicillin, 471%, and carbenicillin, 1001% of wild-type activity
C281Y/N304M
substrate ampicillin, 225%, penicillin G, 277%, phenethicillin, 428%, and carbenicillin, 485% of wild-type activity
C281Y/N304R
C281Y/R306L
substrate ampicillin, 394%, penicillin G, 191%, phenethicillin, 555%, and carbenicillin, 1010% of wild-type activity
C281Y/R307L
substrate ampicillin, 274%, penicillin G, 334%, phenethicillin, 520%, and carbenicillin, 786% of wild-type activity
C37S
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
DELTAI305-310
mutant truncated by six residues, reduced turnover number for penicillin N compared to wild-type enzyme, lower KM-value for penicillin N compared to wild-type enzyme
DELTAK310-314
mutant truncated by five residues, increased turnover number for penicillin N compared to wild-type enzyme, lower KM-value for penicillin N compared to wild-type enzyme, lower Km-value for penicillin G compared to wild-type enzyme, slightly higher turnover number for penicillin G compared to wild-type enzyme
DELTAR306-310
mutant truncated by five residues, reduced turnover number for penicillin N compared to wild-type enzyme, lower KM-value for penicillin N compared to wild-type enzyme
DELTAR307-310
mutant in which residues 307-310 are excised, reduced turnover number for penicillin N compared to wild-type enzyme, higher KM-value for penicillin N compared to wild-type enzyme, increased KM-value for penicillin G compared to wild-type enzyme, increased turnover-number for penicillin G compared to wild-type enzyme
E144K/M188I/A198T/V275I/C281Y
160% relative activity with 1 mM and 200% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
G300V
G79E
H244Q
I305L
I305M
I305M/S261M
-
site-directed mutagenesis, the mutant shows increased activity with penicillin G compared to the wild-type enzyme
I305M/T213V
-
site-directed mutagenesis, the mutant shows increased activity with penicillin G compared to the wild-type enzyme
I305M/T213V/M73T
-
site-directed mutagenesis, the mutant shows increased activity with penicillin G compared to the wild-type enzyme
I305M/T213V/S261M
-
site-directed mutagenesis, the mutant shows increased activity with penicillin G compared to the wild-type enzyme
L277Q
L277Q/I305M
610% relative activity with 1 mM and 520% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
M188I
90% relative activity with 1 mM and 190% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G, epPCR random mutagenesis
M188V
M188V/V275I/G300V
440% relative activity with 1 mM and 310% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
M73T
M73T/C155Y/Y184H/T213V/V275I/C281Y/I305M
site-directed mutagenesis, the mutant shows 22fold increased specific activity and 81fold increased kcat/Km for penicillin G compared to the wild-type
M73T/C281Y
610% relative activity with 1 mM and 530% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
M73T/G300V/I305L
640% relative activity with 1 mM and 380% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
M73T/I118V/A140V/H244Q/C281Y
450% relative activity with 1 mM and 350% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
M73T/I277Q
350% relative activity with 1 mM and 350% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
N304A
N304A/R306L
substrate ampicillin, 214%, penicillin G, 114%, phenethicillin, 319%, and carbenicillin, 393% of wild-type activity
N304K
N304K/R306L
substrate ampicillin, 245%, penicillin G, 80%, phenethicillin, 380%, and carbenicillin, 482% of wild-type activity
N304L
N304L/R306L
substrate ampicillin, 145%, penicillin G, 40%, phenethicillin, 185%, and carbenicillin, 218% of wild-type activity
N304M
substrate ampicillin, 120%, penicillin G,92%, phenethicillin, 127%, and carbenicillin, 161% of wild-type activity
N304M/R306L
substrate ampicillin, 194%, penicillin G, 72%, phenethicillin, 245%, and carbenicillin, 232% of wild-type activity
N304R
N304R/R306L
substrate ampicillin, 256%, penicillin G, 92%, phenethicillin, 344%, and carbenicillin, 514% of wild-type activity
Q126M
R135Q/C155Y/R179Q/M188V/I305M
360% relative activity with 1 mM and 290% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
R160L
mutation abolishes the activity of scDAOCS indicating the importance of these residue in binding the penicillin substrate
R258A
R258F
R258H
R258K
site-directed mutagenesis, broadened specificity for the cosubstrate compared to the wild-type enzyme, mutant enzyme can utilize hydrophobic 2-oxoacids, activity is decreased compared to the wild-type enzyme
R258L
R258Q
R266L
R266Q
-
2-oxoglutarate conversion is very low and the same whether penicillin N, penicillin G or no penicillin substrate is present
R306A
substrate ampicillin, 46%, penicillin G, 37%, phenethicillin, 30%, and carbenicillin, 27% of wild-type activity
R306C
substrate ampicillin, 18%, penicillin G, 13%, phenethicillin, 11%, of wild-type activity
R306D
substrate ampicillin, 8%, penicillin G, 4%, phenethicillin, 4%, of wild-type activity
R306E
substrate ampicillin, 8%, penicillin G, 7%, phenethicillin, 6%,of wild-type activity
R306F
substrate ampicillin, 55%, penicillin G, 41%, phenethicillin, 44%, and carbenicillin, 39% of wild-type activity
R306G
substrate ampicillin, 21%, penicillin G, 27%, phenethicillin, 19%, of wild-type activity
R306H
substrate ampicillin, 16%, penicillin G, 10%, phenethicillin, 8%, of wild-type activity
R306I
R306K
substrate ampicillin, 50%, penicillin G, 53%, phenethicillin, 45%, and carbenicillin, 32% of wild-type activity
R306L
R306M
R306N
substrate ampicillin, 16%, penicillin G, 14%, phenethicillin, 12%, and carbenicillin, 16% of wild-type activity
R306P
R306Q
substrate ampicillin, 62%, penicillin G, 67%, phenethicillin, 54%, and carbenicillin, 62% of wild-type activity
R306S
substrate ampicillin, 39%, penicillin G, 37%, phenethicillin, 27%, and carbenicillin, 30% of wild-type activity
R306T
substrate ampicillin, 40%, penicillin G, 52%, phenethicillin, 32%, and carbenicillin, 34% of wild-type activity
R306V
substrate ampicillin, 34%, penicillin G, 28%, phenethicillin, 36%, and carbenicillin, 32% of wild-type activity
R306W
substrate ampicillin, 90%, penicillin G, 61%, phenethicillin, 82%, and carbenicillin, 83% of wild-type activity
R306Y
substrate ampicillin, 70%, penicillin G, 59%, phenethicillin, 61%, and carbenicillin, 60% of wild-type activity
R307L
R307Q
-
mutation enhances penicillin N conversion compared to the level of wild-type enzyme, turnover number for penicillin N is increased, no enhancement in activity with penicillin G as substrate. Mutation increase the Km-value by 10fold, but has little effect on the turnover number for penicillin G
R74I
-
turnover number and Km-values are similar to that for wild-type enzyme. 2-Oxoglutarate conversion is significantly stimulated in presence of penicillin N and penicillin G compared to wild type enzyme. Penicillin oxidation is reduced relative to the wild type enzyme
R74L
mutation abolishes the activity of scDAOCS indicating the importance of these residue in binding the penicillin substrate
R74Q
-
turnover number and Km-values are similar to that for wild-type enzyme. 2-Oxoglutarate conversion is significantly stimulated in presence of penicillin N and penicillin G compared to wild type enzyme. Penicillin oxidation is reduced relative to the wild type enzyme
R74Q/R266I
-
2-oxoglutarate conversion is not stimulated by penicillin substrates
R74Q/R266Q
-
2-oxoglutarate conversion is not stimulated by penicillin substrates
R75I/D270G
-
2-oxoglutarate conversion is not stimulated by penicillin substrates
R75Q
-
turnover number and Km-values are similar to that for wild-type enzyme. 2-Oxoglutarate conversion is significantly stimulated in presence of penicillin N compared to wild type enzyme
S261A
S261I
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
S261L
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
S261M
S261V
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
S59T
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
T213V
T42A
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
T91A
V275I
V275I/C281Y
260% relative activity with 1 mM and 310% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
V275I/C281Y/G300V
620% relative activity with 1 mM and 380% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
V275I/C281Y/I305M
-
site-directed mutagenesis, exchange of residue surrounding the substrate, over 32fold increased activity compared to the wild-type enzyme
V275I/I305L
310% relative activity with 1 mM and 330% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
V275I/I305M
V275I/N304A
substrate ampicillin, 265%, penicillin G, 233%, phenethicillin, 330%, and carbenicillin,721% of wild-type activity
V275I/N304K
substrate ampicillin, 334%, penicillin G, 294%, phenethicillin, 635%, and carbenicillin, 867% of wild-type activity
V275I/N304L
substrate ampicillin, 225%, penicillin G, 141%, phenethicillin, 245%, and carbenicillin, 524% of wild-type activity
V275I/N304M
substrate ampicillin, 160%, penicillin G, 174%, phenethicillin, 261%, and carbenicillin, 230% of wild-type activity
V275I/N304R
substrate ampicillin, 360%, penicillin G, 381%, phenethicillin, 698%, and carbenicillin,814% of wild-type activity
V275I/R306L
substrate ampicillin, 343%, penicillin G, 168%, phenethicillin, 379%, and carbenicillin, 665% of wild-type activity
V275I/R307L
substrate ampicillin, 172%, penicillin G, 169%, phenethicillin, 238%, and carbenicillin, 333% of wild-type activity
V275L
substrate ampicillin, 85%, penicillin G, 130%, phenethicillin, 99%, and carbenicillin, 113% of wild-type activity
V51A
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
Y184A
-
site-directed mutagenesis, the mutant shows activity increased to 143.9% with penicillin G compared to the wild-type
Y184H
Y184H/H244Q/T259I/L277Q
320% relative activity with 1 mM and 310% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
Y184H/M188I/C281Y/I305L
610% relative activity with 1 mM and 460% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
Y184I
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
Y184L
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
Y184M
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
C155Y/Y184H/S261M/V275I/C281Y/I305M
-
site-directed mutagenesis, the mutant shows 87fold increased kcat/Km for penicillin G compared to the wild-type
-
C155Y/Y184H/V275I/C281Y
-
site-directed mutagenesis, quaternary mutant from error-prone PCR, the mutant shows 41fold increased kcat/Km for penicillin G compared to the wild-type
-
C37S
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
-
M73T/C155Y/Y184H/T213V/V275I/C281Y/I305M
-
site-directed mutagenesis, the mutant shows 22fold increased specific activity and 81fold increased kcat/Km for penicillin G compared to the wild-type
-
T42A
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
-
V51A
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type
-
Y184A
-
site-directed mutagenesis, the mutant shows activity increased to 143.9% with penicillin G compared to the wild-type
-
R258L
-
mutant have the same catalytic activity as the R258Q mutant when 2-oxo-4-methylpentanoate is used as a co-substrate
-
R258Q
-
mutation in scDAOCS almost abolishes the oxidation of both penicillin N and penicillin G, aliphatic 2-oxoacids (2-oxo-4-methylpentanoate and 2-oxo-3-methylbutanoate), which can not replace the function of 2-oxoglutarate for the wild-type enzyme, are able to rescue the catalytic activity of the R258Q mutant to the level observed for the wild-type enzyme
-
R266L
-
mutation abolishes the activity of scDAOCS indicating the importance of these residue in binding the penicillin substrate
-
R74L
-
mutation abolishes the activity of scDAOCS indicating the importance of these residue in binding the penicillin substrate
-
additional information
site-directed mutagenesis, mutant shows no hydroxylation of desacetylcephalosporin C
M306I
hydroxylation reaction of deacetoxycephalosporin C, E C1.14.11.26, is abolished, 59% of wild-type ring expansion activity
107% of wild-type ring expansion activity, 85% of wild-type hydroxylation activity
N305L
-
improved ability to convert penicillin analogs in ring expansion reaction of EC 1.14.20.1
-
improved ability to convert penicillin analogs in ring expansion reaction of EC 1.14.20.1
R308L
-
site-directed mutagenesis, the mutant shows significant improvement in the ability to convert penicillin analogues compared to the wild-type enzyme
site-directed mutagenesis, mutant shows reduced ring expansion activity with artificial substrate penicillin G
W82A
5.5% of wild-type ring expansion activity, 71% of wild-type hydroxylation activity
C155Y
90% relative activity with 1 mM and 180% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G, 1.5fold reduction in Km, penicillin G as substrate
C155Y
the mutant has 1.5fold increment in kcat/Km value when compared with the wild type enzyme
580% relative activity with 1 mM and 670% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
C155Y/Y184H/V275I/C281Y
mutant with enhanced activity and without substrate inhibition
C155Y/Y184H/V275I/C281Y
-
site-directed mutagenesis, the mutant shows increased activity with penicillin G compared to the wild-type enzyme
C155Y/Y184H/V275I/C281Y
site-directed mutagenesis, quaternary mutant from error-prone PCR, the mutant shows 41fold increased kcat/Km for penicillin G compared to the wild-type
C281Y
-
random mutagenesis, exchange of residue surrounding the substrate, 2-6fold increased activity compared to the wild-type enzyme
C281Y
substrate ampicillin, 166%, penicillin G, 251%, phenethicillin, 280%, and carbenicillin, 572% of wild-type activity
C281Y
the mutant has 6.1fold increment in kcat/Km value when compared with the wild type enzyme
substrate ampicillin, 491%, penicillin G, 495%, phenethicillin, 1109%, and carbenicillin, 1347% of wild-type activity
C281Y/I305M
kcat/Km values of double-mutant scDAOCSs are higher than that of the wild-type enzyme for ampicillin conversion, improvement in the enzymes catalytic effciency (68fold increment)
substrate ampicillin, 430%, penicillin G, 441%, phenethicillin, 1041%, and carbenicillin, 1309% of wild-type activity
C281Y/N304R
kcat/Km values of double-mutant scDAOCSs are higher than that of the wild-type enzyme for ampicillin conversion, improvement in the enzymes catalytic effciency (101fold increment)
410% relative activity with 1 mM and 370% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
-
random mutagenesis, exchange of residue surrounding the substrate, 2-6fold increased activity compared to the wild-type enzyme
G79E
the mutant has 2.3fold increment in kcat/Km value when compared with the wild type enzyme
140% relative activity with 1 mM and 270% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G, 1.9fold reduction in Km, penicillin G as substrate, epPCR random mutagenesis
H244Q
the mutant has 2.8fold increment in kcat/Km value when compared with the wild type enzyme
-
site-directed mutagenesis, exchange of residue surrounding the substrate, 6-14fold increased activity compared to the wild-type enzyme
I305L
the mutant has 6.4fold increment in kcat/Km value when compared with the wild type enzyme
I305L
-
site-directed mutagenesis, the mutant shows increased activity with penicillin G compared to the wild-type enzyme
-
site-directed mutagenesis, exchange of residue surrounding the substrate, 6-14fold increased activity compared to the wild-type enzyme
I305M
substrate ampicillin, 313%, penicillin G, 234%, phenethicillin, 318%, and carbenicillin, 450% of wild-type activity
I305M
the mutant has 10.8fold increment in kcat/Km value when compared with the wild type enzyme
I305M
-
site-directed mutagenesis, the mutant shows increased activity with penicillin G compared to the wild-type enzyme
270% relative activity with 1 mM and 410% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G, 2.5fold reduction in Km, penicillin G as substrate
L277Q
the mutant has 5.7fold increment in kcat/Km value when compared with the wild type enzyme
150% relative activity with 1 mM and 190% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G, epPCR random mutagenesis
M188V
the mutant has 3.3fold increment in kcat/Km value when compared with the wild type enzyme
M73T
180% relative activity with 1 mM and 250% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G, 3.5fold reduction in Km for penicillin N and 2.3fold reduction in Km for penicillin G, epPCR random mutagenesis
M73T
the mutant has 4.7fold increment in kcat/Km value when compared with the wild type enzyme
substrate ampicillin, 192%, penicillin G, 163%, phenethicillin, 163%, and carbenicillin, 242% of wild-type activity
N304A
mutation is able to increase the activity of the enzyme
N304K
-
site-directed mutagenesis, exchange of residue surrounding the substrate, 6-14fold increased activity compared to the wild-type enzyme
N304K
substrate ampicillin, 270%, penicillin G, 237%, phenethicillin, 211%, an carbenicillin, 404% of wild-type activity
N304K
the mutant has 14.2fold increment in kcat/Km value when compared with the wild type enzyme
mutant enzyme with improved efficiency in penicillin conversion
N304L
mutant enzyme shows increased penicillin analog conversion
N304L
substrate ampicillin, 163%, penicillin G, 129%, phenethicillin, 173%, and carbenicillin, 235% of wild-type activity
substrate ampicillin, 346%, penicillin G, 263%, phenethicillin, 360%, and carbenicillin, 398% of wild-type activity
N304R
improvement of the substrate-binding affinity of the enzyme for ampicillin conversion
Q126M
-
site-directed mutagenesis, the mutant shows activity increased to 281.5% with penicillin G compared to the wild-type
wild-type enzyme has a requirement for 2-oxoglutarate and cannot efficiently use hydrophobic 2-oxoacids, the mutant enzyme has broadened cosubstrate selectivity and is able to utilize hydrophobic 2-oxoacids. The efficiency of 2-oxoglutarate utilization is decreased as compared to the wild-type enzyme
R258A
site-directed mutagenesis, broadened specificity for the cosubstrate compared to the wild-type enzyme, mutant enzyme can utilize hydrophobic 2-oxoacids, activity is decreased compared to the wild-type enzyme
wild-type enzyme has a requirement for 2-oxoglutarate and cannot efficiently use hydrophobic 2-oxoacids, the mutant enzyme has broadened cosubstrate selectivity and is able to utilize hydrophobic 2-oxoacids. The efficiency of 2-oxoglutarate utilization is decreased as compared to the wild-type enzyme
R258F
site-directed mutagenesis, broadened specificity for the cosubstrate compared to the wild-type enzyme, mutant enzyme can utilize hydrophobic 2-oxoacids, activity is decreased compared to the wild-type enzyme
wild-type enzyme has a requirement for 2-oxoglutarate and cannot efficiently use hydrophobic 2-oxoacids, the mutant enzyme has broadened cosubstrate selectivity and is able to utilize hydrophobic 2-oxoacids. The efficiency of 2-oxoglutarate utilization is decreased as compared to the wild-type enzyme
R258H
site-directed mutagenesis, broadened specificity for the cosubstrate compared to the wild-type enzyme, mutant enzyme can utilize hydrophobic 2-oxoacids, activity is decreased compared to the wild-type enzyme
wild-type enzyme has a requirement for 2-oxoglutarate and cannot efficiently use hydrophobic 2-oxoacids, the mutant enzyme has broadened cosubstrate selectivity and is able to utilize hydrophobic 2-oxoacids. The efficiency of 2-oxoglutarate utilization is decreased as compared to the wild-type enzyme
R258L
site-directed mutagenesis, broadened specificity for the cosubstrate compared to the wild-type enzyme, mutant enzyme can utilize hydrophobic 2-oxoacids, activity is decreased compared to the wild-type enzyme
R258L
mutant have the same catalytic activity as the R258Q mutant when 2-oxo-4-methylpentanoate is used as a co-substrate
site-directed mutagenesis, broadened specificity for the cosubstrate compared to the wild-type enzyme, mutant enzyme can utilize hydrophobic 2-oxoacids, activity is decreased compared to the wild-type enzyme
R258Q
mutation in scDAOCS almost abolishes the oxidation of both penicillin N and penicillin G, aliphatic 2-oxoacids (2-oxo-4-methylpentanoate and 2-oxo-3-methylbutanoate), which can not replace the function of 2-oxoglutarate for the wild-type enzyme, are able to rescue the catalytic activity of the R258Q mutant to the level observed for the wild-type enzyme
-
2-oxoglutarate conversion is very low and the same whether penicillin N, penicillin G or no penicillin substrate is present
R266L
mutation abolishes the activity of scDAOCS indicating the importance of these residue in binding the penicillin substrate
substrate ampicillin, 168%, penicillin G, 113%, phenethicillin, 149%, and carbenicillin, 167% of wild-type activity
R306I
replacement of R306 with amino acids structurally similar to leucine is able to improve the enzyme activity via hydrophobic interaction with the surrounding residues
mutant enzyme with improved efficiency in penicillin conversion
R306L
-
mutation enhances penicillin N conversion compared to the level of wild-type enzyme, turnover number for penicillin N is increased, no enhancement in activity with penicillin G as substrate, little effect on kinetic values using penicillin G as substrate
R306L
substrate ampicillin, 186%, penicillin G, 105%, phenethicillin, 173%, and carbenicillin, 283% of wild-type activity
R306L
-
substrate ampicillin, 186%, penicillin G, 105%, phenethicillin, 173%, and carbenicillin, 283% of wild-type activity
substrate ampicillin, 113%, penicillin G, 102%, phenethicillin, 115%, and carbenicillin, 122% of wild-type activity
R306M
replacement of R306 with amino acids structurally similar to leucine is able to improve the enzyme activity via hydrophobic interaction with the surrounding residues
mutant enzyme with improved efficiency in penicillin conversion
R307L
substrate ampicillin, 133%, penicillin G, 124%, phenethicillin, 122%, and carbenicillin, 108% of wild-type activity
S261A
-
site-directed mutagenesis, the mutant shows activity increased to 128.8% with penicillin G compared to the wild-type
S261M
-
site-directed mutagenesis, the mutant shows activity increased to 158.4% with penicillin G compared to the wild-type
T213V
-
site-directed mutagenesis, the mutant shows activity increased to 172.4% with penicillin G compared to the wild-type
110% relative activity with 1 mM and 200% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G, 1.9fold reduction in Km, penicillin G as substrate, epPCR random mutagenesis
T91A
the mutant has 2.1fold increment in kcat/Km value when compared with the wild type enzyme
V275I
-
random mutagenesis, exchange of residue surrounding the substrate, 2-6fold increased activity compared to the wild-type enzyme
V275I
substrate ampicillin, 129%, penicillin G, 157%, phenethicillin, 150%, and carbenicillin, 227% of wild-type activity
V275I
the mutant has 1.7fold increment in kcat/Km value when compared with the wild type enzyme
-
site-directed mutagenesis, exchange of residue surrounding the substrate, 32fold increased activity compared to the wild-type enzyme
V275I/I305M
substrate ampicillin, 406%, penicillin G, 420%, phenethicillin, 685%, and carbenicillin, 1057% of wild-type activity
V275I/I305M
the mutant has 32.4fold increment in kcat/Km value when compared with the wild type enzyme
Y184H
200% relative activity with 1 mM and 330% relative activity with 10 mM substrate penicillin G compared to wild-type activity detected with 1 mM penicillin G
Y184H
the mutant has 4.7fold increment in kcat/Km value when compared with the wild type enzyme
-
DELTA310 is a C-terminally truncated mutant lacking residues 1-309, the mutant shows 2fold enhanced ring expansion activity with the artificial substrate penicillin G
additional information
DELTA310 is a C-terminally truncated mutant lacking residues 1-309, the mutant shows 2fold enhanced ring expansion activity with the artificial substrate penicillin G
additional information
-
truncation of C-terminus to residue 310, 2fold enhancement of ring expansion reaction of penicillin G. Double mutant with truncation at residue 310 and M306I, selective catalyzation of ring expansion. Triple mutant with truncation at residue 310, M306I and N305L, selective catalization of ring expansion with improved kinetic parameters
additional information
truncation of C-terminus to residue 310, 2fold enhancement of ring expansion reaction of penicillin G. Double mutant with truncation at residue 310 and M306I, selective catalyzation of ring expansion. Triple mutant with truncation at residue 310, M306I and N305L, selective catalization of ring expansion with improved kinetic parameters
additional information
recombinant expression of Streptomyces clavuligerus scDAOCS in a cefEF-disrupted cephalosporin C production Acremonium chrysogenum strain, which converts penicillin N accumulated in the disruption strain to deacetoxycephalosporin C
additional information
-
mutations to obtain a wider substrate specificity for DAOCS are very important since modification of the DAOCS activity to accept hydrophobic penicillins is of great industrial interest
additional information
the truncation of the C-terminus at position 310 in the wild-type enzyme results in reduction of indiscriminate conversion of penicillin analog but this defect is compensated by the replacement of asparagine with leucine at position 304
additional information
-
the truncation of the C-terminus at position 310 in the wild-type enzyme results in reduction of indiscriminate conversion of penicillin analog but this defect is compensated by the replacement of asparagine with leucine at position 304
additional information
shortening of the C-terminus by more than 4 residues reduces enzyme activity and alters the crystal structure from merohedrally twinned trimeric crystals to a non-trimeric structure with a free C-terminal arm, crystals show no twinning
additional information
-
shortening of the C-terminus by more than 4 residues reduces enzyme activity and alters the crystal structure from merohedrally twinned trimeric crystals to a non-trimeric structure with a free C-terminal arm, crystals show no twinning
additional information
-
since the natural substrate of the enzyme, penicillin N, is not available in large quantities, engineering of a scDAOCS capable of converting the cheap and easily available substrate penicillin G is valuable for large-scale production of 7-aminodeacetoxycephalosporanic acid, 7-ADCA
additional information
-
since the natural substrate of the enzyme, penicillin N, is not available in large quantities, engineering of a scDAOCS capable of converting the cheap and easily available substrate penicillin G is valuable for large-scale production of 7-aminodeacetoxycephalosporanic acid, 7-ADCA. Ten sites, Y184, V245, S261, C37, T42, V51, S59, A61, Q126, and T213, are mutated to 21 point mutants
additional information
rational mutational approach to generate an engineered strain for enhanced production of from penicillin G, e.g. mutant FF8 from gene shuffling with 118fold increase in kcat/Km
additional information
reconstitution of TCA cycle with enzyme DAOCS to engineer Escherichia coli into an efficient whole cell catalyst of penicillin G, overview. Cumulative effects of different combinations ofDELTAsucA,DELTAaceA,DELTApoxB::acs, and DELTAampC mutations on G- 7-aminodeacetoxycephalosporanic acid (G-7-ADCA) production. Additional engineering steps are taken to reduce the degradation of penicillin G and G-7-ADCA in the bioconversion process. Method optimization and evaluation, effects of deregulation of glyoxylate pathway and increased TCA flux on DAOCS catalyzed reaction, and effects of combining the beneficial mutations on G-7-ADCA production, overview
additional information
-
since the natural substrate of the enzyme, penicillin N, is not available in large quantities, engineering of a scDAOCS capable of converting the cheap and easily available substrate penicillin G is valuable for large-scale production of 7-aminodeacetoxycephalosporanic acid, 7-ADCA. Ten sites, Y184, V245, S261, C37, T42, V51, S59, A61, Q126, and T213, are mutated to 21 point mutants
-
additional information
-
rational mutational approach to generate an engineered strain for enhanced production of from penicillin G, e.g. mutant FF8 from gene shuffling with 118fold increase in kcat/Km
-
additional information
-
reconstitution of TCA cycle with enzyme DAOCS to engineer Escherichia coli into an efficient whole cell catalyst of penicillin G, overview. Cumulative effects of different combinations ofDELTAsucA,DELTAaceA,DELTApoxB::acs, and DELTAampC mutations on G- 7-aminodeacetoxycephalosporanic acid (G-7-ADCA) production. Additional engineering steps are taken to reduce the degradation of penicillin G and G-7-ADCA in the bioconversion process. Method optimization and evaluation, effects of deregulation of glyoxylate pathway and increased TCA flux on DAOCS catalyzed reaction, and effects of combining the beneficial mutations on G-7-ADCA production, overview
-